Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting mTOR With Everolimus and/or Physical Training for Preventing Postmenopausal Bone Loss and Accelerated Skeletal Aging: The RapaLoad Study

NCT06789900 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06789900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06789900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting mTOR With Everolimus and/or Physical Training for Preventing Postmenopausal Bone Loss and Accelerated Skeletal Aging: The RapaLoad Study
Lead sponsor
Odense University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 14, 2024
Completion date
October 1, 2026
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal women